Latest market headlines for ZYDUSLIFE on Terminal.
26-Sept-2026 12:25:40
• USFDA conducted an onsite inspection of pharmacovigilance and post marketing surveillance system at the company's office in New Jersey, USA. • The inspection…
31-Aug-2026 10:44:07
• Zydus Lifesciences Limited has announced positive topline results from its completed EVIDENCES-X Phase II(b) clinical trial of Saroglitazar Mg in MASH. • The…
21-Aug-2026 13:53:10
• Ascorbic Acid Injection USP, 25,000 mg/50 mL (500 mg/mL), 5,000 mg/10 mL (500 mg/mL) receives final USFDA approval. • Primarily used for short-term treatment…
03-Jul-2026 12:22:26
• Zydus Lifesciences has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the Shield™™ Multi-Cancer Detection (MCD) test in India. • T…
29-Jun-2026 14:36:53
• The company has mutually agreed to extend the closing date for the acquisition of Sterling Biotech Limited's API business. • The new closing date is now Sept…
26-Jun-2026 07:56:05
• Joint venture 'Zydus Sunshine Lifesciences' to establish pharmaceutical manufacturing facility in Horana, Sri Lanka • Investment commitment of over USD 20 mi…
19-Jun-2026 18:04:36
• The company extinguished 87,30,158 (eighty seven lakh thirty thousand one hundred and fifty eight) fully paid-up equity shares. • These shares were bought ba…